Urology · Fresno, CA
NPI
1629073226
Since 2005
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7014 N Whitney Ave, Ste A
Fresno, CA, 93720
Phone (559) 321-2800
Groups this clinician bills Medicare through
Medicare paid, 2024
$870K
26,572 services
Medicare patients, 2024
1,005
Average age 75
Drug cost, 2024
$486K
2,505 prescriptions
Company payments, 2025
$16K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William M Schiff was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 5,495 times for 54 patients. In total William M Schiff billed 26,572 services in 96 codes, and Medicare paid $870K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,495 | 54 | $0.10 | $567 |
| 99214 Office E&M - Established | Office | 2,078 | 762 | $97.69 | $203K |
| J3490 Unclassified drugs | Office | 1,642 | 93 | $73.93 | $121K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,592 | 686 | $12.74 | $20K |
| 51798 Ultrasound - Nonspecific | Office | 1,206 | 694 | $9.26 | $11K |
| 81003 Clinical Chemistry | Office | 1,204 | 727 | $2.19 | $2,634 |
| 36415 Venipuncture Blood Collection | Office | 570 | 402 | $7.96 | $4,538 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 392 | 84 | $50.80 | $20K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 291 | 76 | $39.12 | $11K |
| 11980 Skin | Office | 262 | 82 | $72.65 | $19K |
| 99213 Office E&M - Established | Office | 214 | 188 | $69.96 | $15K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 198 | 37 | $49.61 | $9,822 |
| 52000 Cystourethroscopy | Office | 163 | 151 | $195.25 | $32K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 120 | 16 | $139.15 | $17K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 111 | 104 | $82.03 | $9,105 |
By year: 2022 $819K for 24,701 services; 2023 $842K for 22,792 services; 2024 $870K for 26,572 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,204 | 727 | $2.19 | $2,634 |
| 36415 Venipuncture Blood Collection | 570 | 402 | $7.96 | $4,538 |
| 88108 Surgical Pathology Examination | 55 | 47 | $38.18 | $2,100 |
Medicare prescription drug claims, 2024
In 2024, the drug William M Schiff prescribed most often to Medicare patients was Tamsulosin Hcl, with 863 prescriptions and refills. In total William M Schiff wrote 2,505 Medicare prescriptions that cost $486K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 863 | 2,003 | 270 | $18K |
| Oxybutynin Chloride Generic | 290 | 564 | 105 | $6,649 |
| Finasteride Generic | 272 | 638 | 87 | $3,789 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 126 | 132 | 106 | $444 |
| Testosterone Generic | 109 | 227 | 42 | $30K |
| Estradiol Generic | 91 | 180 | 46 | $5,543 |
| Solifenacin Succinate Generic | 79 | 151 | 26 | $2,891 |
| Cephalexin Generic | 76 | 76 | 64 | $343 |
| Myrbetriq Mirabegron | 56 | 90 | 15 | $40K |
| Gemtesa Vibegron | 44 | 83 | 14 | $39K |
| Doxazosin Mesylate Generic | 42 | 117 | 15 | $683 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 31 | 79 | Under 11 | $1,223 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 28 | 28 | 13 | $887 |
| Ciprofloxacin Hcl Generic | 26 | 26 | 24 | $96.74 |
| Imipramine Hcl Generic | 24 | 40 | Under 11 | $758 |
Brand drugs: - claims; generic drugs: 2,343 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William M Schiff $16K ($991 in general payments such as food, travel and fees and $15K for research) from 17 companies. The largest payer was Dendreon Pharmaceuticals LLC with $15K.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 2 | $15K |
| Antares Pharma, Inc. | 21 | $394 |
| Astellas Pharma US Inc 4503.T | 2 | $168 |
| Boston Scientific Corporation BSX | 2 | $92.54 |
| Ferring Pharmaceuticals Inc. | 2 | $90.7 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $82.76 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $42.5 |
| Teleflex LLC TFX | 1 | $30.19 |
| Profound Medical Corp. PROF | 1 | $27.06 |
| Abbvie Inc. ABBV | 1 | $25.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.